CGABL
The Carlyle Group Inc. 4.625% Subordinated Notes due 2061
Financial - Credit Services
Market Cap$6.07B
5Y Perf.-33.4%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
CGABL vs MS
Revenue, margins, valuation, and 5-year total return — side by side.
MS
Morgan Stanley
Financial - Capital Markets
Market Cap$307.53B
5Y Perf.+112.5%
CGABL vs MS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | CGABL | MS |
|---|---|---|
| Industry | Financial - Credit Services | Financial - Capital Markets |
| Market Cap | $6.07B | $307.53B |
| Revenue (TTM) | $5.43B | $103.14B |
| Net Income (TTM) | $773M | $16.18B |
| Gross Margin | 50.1% | 55.6% |
| Operating Margin | 25.2% | 17.1% |
| Forward P/E | 6.1x | 16.3x |
| Total Debt | $0.00 | $360.49B |
| Cash & Equiv. | $1.27B | $75.74B |
CGABL vs MS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
CGABL
MS
| Stock | May 21 | May 26 | Return |
|---|---|---|---|
| The Carlyle Group I… (CGABL) | 100 | 66.6 | -33.4% |
| Morgan Stanley (MS) | 100 | 212.5 | +112.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CGABL vs MS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: CGABL leads in 6 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Morgan Stanley is the stronger pick specifically for recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
CGABL
The Carlyle Group Inc. 4.625% Subordinated Notes due 2061
The Banking Pick
CGABL carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 0 yrs, beta 0.71, yield 8.1%
- Rev growth 83.1%, EPS growth 264.9%
- Lower volatility, beta 0.71, current ratio 14.94x
Best for: income & stability and growth exposure
MS
Morgan Stanley
The Banking Pick
MS is the clearest fit if your priority is long-term compounding.
- 7.4% 10Y total return vs CGABL's -9.1%
- +66.7% vs CGABL's +5.1%
Best for: long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | CGABL | 83.1% NII/revenue growth vs MS's 16.8% |
| Value | CGABL | Lower P/E (6.1x vs 16.3x) |
| Quality / Margins | CGABL | Efficiency ratio 0.2% vs MS's 0.4% (lower = leaner) |
| Stability / Safety | CGABL | Beta 0.71 vs MS's 1.37 |
| Dividends | CGABL | 8.1% yield, vs MS's 2.0% |
| Momentum (1Y) | MS | +66.7% vs CGABL's +5.1% |
| Efficiency (ROA) | CGABL | Efficiency ratio 0.2% vs MS's 0.4% |
CGABL vs MS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2024
FY 2024
CGABL vs MS — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLCGABLLAGGINGMS
MSMorgan Stanley
1leads
CGABLThe Carlyle Group Inc…
3leads
6 Total Categories
CATEGORYLEADERvs MSMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
CGABL3/5
Valuation MetricsMultiples, price ratios, and targets
CGABL4/4
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
CGABL7/8
Total Returns1Y, 3Y, 5Y total returns with dividends
MS6/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
Tied
—
Income & Cash Flow (Last 12 Months)
CGABL leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
MS is the larger business by revenue, generating $103.1B annually — 19.0x CGABL's $5.4B. CGABL is the more profitable business, keeping 18.8% of every revenue dollar as net income compared to MS's 13.0%.
| Metric | CGABLThe Carlyle Group… | MSMorgan Stanley |
|---|---|---|
| RevenueTrailing 12 months | $5.4B | $103.1B |
| EBITDAEarnings before interest/tax | $249M | $26.3B |
| Net IncomeAfter-tax profit | $773M | $16.2B |
| Free Cash FlowCash after capex | $1.1B | -$6.7B |
| Gross MarginGross profit ÷ Revenue | +50.1% | +55.6% |
| Operating MarginEBIT ÷ Revenue | +25.2% | +17.1% |
| Net MarginNet income ÷ Revenue | +18.8% | +13.0% |
| FCF MarginFCF ÷ Revenue | +18.6% | -2.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -81.6% | +48.9% |
CGABL leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
CGABL leads this category, winning 4 of 4 comparable metrics.
Valuation Metrics
At 6.1x trailing earnings, CGABL trades at a 75% valuation discount to MS's 24.3x P/E. On an enterprise value basis, CGABL's 3.1x EV/EBITDA is more attractive than MS's 26.0x.
| Metric | CGABLThe Carlyle Group… | MSMorgan Stanley |
|---|---|---|
| Market CapShares × price | $6.1B | $307.5B |
| Enterprise ValueMkt cap + debt − cash | $4.8B | $592.3B |
| Trailing P/EPrice ÷ TTM EPS | 6.08x | 24.31x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 16.28x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.73x |
| EV / EBITDAEnterprise value multiple | 3.09x | 26.03x |
| Price / SalesMarket cap ÷ Revenue | 1.12x | 2.98x |
| Price / BookPrice ÷ Book value/share | 0.88x | 2.95x |
| Price / FCFMarket cap ÷ FCF | 6.00x | — |
CGABL leads this category, winning 4 of 4 comparable metrics.
Profitability & Efficiency
CGABL leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
MS delivers a 14.6% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $10 for CGABL. On the Piotroski fundamental quality scale (0–9), CGABL scores 6/9 vs MS's 5/9, reflecting solid financial health.
| Metric | CGABLThe Carlyle Group… | MSMorgan Stanley |
|---|---|---|
| ROE (TTM)Return on equity | +9.6% | +14.6% |
| ROA (TTM)Return on assets | +2.9% | +1.2% |
| ROICReturn on invested capital | +15.3% | +2.9% |
| ROCEReturn on capital employed | +6.2% | +3.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | — | 3.42x |
| Net DebtTotal debt minus cash | -$1.3B | $284.7B |
| Cash & Equiv.Liquid assets | $1.3B | $75.7B |
| Total DebtShort + long-term debt | $0 | $360.5B |
| Interest CoverageEBIT ÷ Interest expense | 2.60x | 0.44x |
CGABL leads this category, winning 7 of 8 comparable metrics.
Total Returns (Dividends Reinvested)
MS leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MS five years ago would be worth $24,217 today (with dividends reinvested), compared to $9,092 for CGABL. Over the past 12 months, MS leads with a +66.7% total return vs CGABL's +5.1%. The 3-year compound annual growth rate (CAGR) favors MS at 34.3% vs CGABL's 3.5% — a key indicator of consistent wealth creation.
| Metric | CGABLThe Carlyle Group… | MSMorgan Stanley |
|---|---|---|
| YTD ReturnYear-to-date | +0.3% | +7.4% |
| 1-Year ReturnPast 12 months | +5.1% | +66.7% |
| 3-Year ReturnCumulative with dividends | +11.0% | +142.1% |
| 5-Year ReturnCumulative with dividends | -9.1% | +142.2% |
| 10-Year ReturnCumulative with dividends | -9.1% | +739.4% |
| CAGR (3Y)Annualised 3-year return | +3.5% | +34.3% |
MS leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
Evenly matched — CGABL and MS each lead in 1 of 2 comparable metrics.
Risk & Volatility
CGABL is the less volatile stock with a 0.71 beta — it tends to amplify market swings less than MS's 1.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MS currently trades 99.2% from its 52-week high vs CGABL's 89.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | CGABLThe Carlyle Group… | MSMorgan Stanley |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.71x | 1.37x |
| 52-Week HighHighest price in past year | $18.80 | $194.83 |
| 52-Week LowLowest price in past year | $6.86 | $117.21 |
| % of 52W HighCurrent price vs 52-week peak | +89.7% | +99.2% |
| RSI (14)Momentum oscillator 0–100 | 47.3 | 61.2 |
| Avg Volume (50D)Average daily shares traded | 31K | 5.4M |
Evenly matched — CGABL and MS each lead in 1 of 2 comparable metrics.
Analyst Outlook
Evenly matched — CGABL and MS each lead in 1 of 2 comparable metrics.
Analyst Outlook
For income investors, CGABL offers the higher dividend yield at 8.11% vs MS's 1.97%.
| Metric | CGABLThe Carlyle Group… | MSMorgan Stanley |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $205.75 |
| # AnalystsCovering analysts | — | 52 |
| Dividend YieldAnnual dividend ÷ price | +8.1% | +2.0% |
| Dividend StreakConsecutive years of raises | 0 | 11 |
| Dividend / ShareAnnual DPS | $1.37 | $3.81 |
| Buyback YieldShare repurchases ÷ mkt cap | +9.1% | +1.4% |
Evenly matched — CGABL and MS each lead in 1 of 2 comparable metrics.
Key Takeaway
CGABL leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). MS leads in 1 (Total Returns). 2 tied.
Best OverallThe Carlyle Group Inc. 4.62… (CGABL)Leads 3 of 6 categories
Loading custom metrics...
CGABL vs MS: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is CGABL or MS a better buy right now?
For growth investors, The Carlyle Group Inc.
4. 625% Subordinated Notes due 2061 (CGABL) is the stronger pick with 83. 1% revenue growth year-over-year, versus 16. 8% for Morgan Stanley (MS). The Carlyle Group Inc. 4. 625% Subordinated Notes due 2061 (CGABL) offers the better valuation at 6. 1x trailing P/E, making it the more compelling value choice. Analysts rate Morgan Stanley (MS) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CGABL or MS?
On trailing P/E, The Carlyle Group Inc.
4. 625% Subordinated Notes due 2061 (CGABL) is the cheapest at 6. 1x versus Morgan Stanley at 24. 3x.
03Which is the better long-term investment — CGABL or MS?
Over the past 5 years, Morgan Stanley (MS) delivered a total return of +142.
2%, compared to -9. 1% for The Carlyle Group Inc. 4. 625% Subordinated Notes due 2061 (CGABL). Over 10 years, the gap is even starker: MS returned +739. 4% versus CGABL's -9. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CGABL or MS?
By beta (market sensitivity over 5 years), The Carlyle Group Inc.
4. 625% Subordinated Notes due 2061 (CGABL) is the lower-risk stock at 0. 71β versus Morgan Stanley's 1. 37β — meaning MS is approximately 93% more volatile than CGABL relative to the S&P 500.
05Which is growing faster — CGABL or MS?
By revenue growth (latest reported year), The Carlyle Group Inc.
4. 625% Subordinated Notes due 2061 (CGABL) is pulling ahead at 83. 1% versus 16. 8% for Morgan Stanley (MS). On earnings-per-share growth, the picture is similar: The Carlyle Group Inc. 4. 625% Subordinated Notes due 2061 grew EPS 264. 9% year-over-year, compared to 53. 5% for Morgan Stanley. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CGABL or MS?
The Carlyle Group Inc.
4. 625% Subordinated Notes due 2061 (CGABL) is the more profitable company, earning 18. 8% net margin versus 13. 0% for Morgan Stanley — meaning it keeps 18. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CGABL leads at 25. 2% versus 17. 1% for MS. At the gross margin level — before operating expenses — MS leads at 55. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Which pays a better dividend — CGABL or MS?
All stocks in this comparison pay dividends.
The Carlyle Group Inc. 4. 625% Subordinated Notes due 2061 (CGABL) offers the highest yield at 8. 1%, versus 2. 0% for Morgan Stanley (MS).
08Is CGABL or MS better for a retirement portfolio?
For long-horizon retirement investors, The Carlyle Group Inc.
4. 625% Subordinated Notes due 2061 (CGABL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 71), 8. 1% yield). Both have compounded well over 10 years (CGABL: -9. 1%, MS: +739. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between CGABL and MS?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(CGABL: 83.1% · MS: 16.8%)Net Margin>
%
(CGABL: 18.8% · MS: 13.0%)P/E Ratio<
x
(CGABL: 6.1x · MS: 24.3x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.